Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clavel

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Revista Clinica Espanola|July 1, 1985
[Cerebral metastasis simulating pinealoma]M Clavel Escribano, J Olier Arenas, J L Zubieta, et al.
Oncology|January 15, 1998
Phase II trial of navelbine and fluorouracil as second-line chemotherapy in metastatic breast carcinomaM E Froudarakis, G Catimel, J P Guastalla, et al.
Revue Des Maladies Respiratoires|June 27, 2001
[Pseudoneoplastic forms of bronchiolitis obliterans with organizing pneumopathy (BOOP)]A Hashemzadeh, M Clavel, C Musso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary GroupM Clavel, S Monfardini, S Fosså, et al.
Presse Medicale (Paris, France : 1983)|June 28, 1997
[Continuous intrathecal injection of baclofen in generalized tetanus. A therapeutic alternative]B François, M Clavel, A Desachy, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 27, 2014
Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicityJulien Dubarle-Offner, Catherine M Clavel, Geoffrey Gontard, et al.
Case Reports in Pulmonology|November 8, 2012
Bortezomib-induced bronchiolitis obliterans organizing pneumoniaE Vandeix, F Favard, N Pichon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studiesJ P Armand, Y M Extra, G Catimel, et al.
Cancer Letters|November 29, 1996
Breast cancer prognostic significance of some modified urinary nucleosidesA J Sasco, F Rey, C Reynaud, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Combination of dacarbazine and mitomycin in advanced colorectal cancerH Bleiberg, M Clavel, C Nicaise, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Revista Clinica Espanola|July 1, 1985
[Cerebral metastasis simulating pinealoma]M Clavel Escribano, J Olier Arenas, J L Zubieta, et al.
Oncology|January 15, 1998
Phase II trial of navelbine and fluorouracil as second-line chemotherapy in metastatic breast carcinomaM E Froudarakis, G Catimel, J P Guastalla, et al.
Revue Des Maladies Respiratoires|June 27, 2001
[Pseudoneoplastic forms of bronchiolitis obliterans with organizing pneumopathy (BOOP)]A Hashemzadeh, M Clavel, C Musso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary GroupM Clavel, S Monfardini, S Fosså, et al.
Presse Medicale (Paris, France : 1983)|June 28, 1997
[Continuous intrathecal injection of baclofen in generalized tetanus. A therapeutic alternative]B François, M Clavel, A Desachy, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 27, 2014
Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicityJulien Dubarle-Offner, Catherine M Clavel, Geoffrey Gontard, et al.
Case Reports in Pulmonology|November 8, 2012
Bortezomib-induced bronchiolitis obliterans organizing pneumoniaE Vandeix, F Favard, N Pichon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studiesJ P Armand, Y M Extra, G Catimel, et al.
Cancer Letters|November 29, 1996
Breast cancer prognostic significance of some modified urinary nucleosidesA J Sasco, F Rey, C Reynaud, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Combination of dacarbazine and mitomycin in advanced colorectal cancerH Bleiberg, M Clavel, C Nicaise, et al.
Pageof 16